Wang, S.-Y.; Tai, Y.-S.; Leung, H.W.C.; Leung, S.H.; Chan, A.L.F.
Cost-Effectiveness of Sacituzumab Govitecan Versus Chemotherapy in Metastatic Triple—Negative Breast Cancer in Taiwan. Cancers 2025, 17, 3305.
https://doi.org/10.3390/cancers17203305
AMA Style
Wang S-Y, Tai Y-S, Leung HWC, Leung SH, Chan ALF.
Cost-Effectiveness of Sacituzumab Govitecan Versus Chemotherapy in Metastatic Triple—Negative Breast Cancer in Taiwan. Cancers. 2025; 17(20):3305.
https://doi.org/10.3390/cancers17203305
Chicago/Turabian Style
Wang, Shyh-Yau, Yun-Sheng Tai, Henry W. C. Leung, Shin Hang Leung, and Agnes L. F. Chan.
2025. "Cost-Effectiveness of Sacituzumab Govitecan Versus Chemotherapy in Metastatic Triple—Negative Breast Cancer in Taiwan" Cancers 17, no. 20: 3305.
https://doi.org/10.3390/cancers17203305
APA Style
Wang, S.-Y., Tai, Y.-S., Leung, H. W. C., Leung, S. H., & Chan, A. L. F.
(2025). Cost-Effectiveness of Sacituzumab Govitecan Versus Chemotherapy in Metastatic Triple—Negative Breast Cancer in Taiwan. Cancers, 17(20), 3305.
https://doi.org/10.3390/cancers17203305